Arrayit Establishes Diagnostics Subsidiary in Houston
August 18, 2009
Arrayit Establishes Diagnostics Subsidiary in Houston
The subsidiary, called Arrayit Diagnostics, will use its parent's chip platform to identify genomic and proteomic biomarkers for specific diseases, with the aim of making early-stage diagnoses.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Arrayit to Spin out Diagnostics Subsidiary to Encourage Investment, Speed Dx Commercialization
December 20, 2011 / BioArray News - Arrayit Q1 Revenues Rise 47 Percent on Microarray Demand
August 9, 2011 / BioArray News - In Print
September 14, 2010 / BioArray News - Arrayit Pursuing PMA from FDA for OvaDx
August 23, 2010 / GenomeWeb Daily News - In Print
June 8, 2010 / BioArray News